|
Volumn 18, Issue 3, 2010, Pages 1213-1226
|
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents
|
Author keywords
Anti HBV; Helioxanthin derivatives; Hepatitis B virus
|
Indexed keywords
10 (3 BENZYLOXY 4 METHOXYPHENYL)FURO[3',4':6,7] NAPHTHO[1,2 D][1,3]DIOXOL 7,9 DIONE;
10 (3 HYDROXY 4 METHOXYPHENYL) 9H FURO[3',4':6,7] NAPHTHO[1,2D][1,3]DIOXOL 7 ONE;
10 (4 TRIFLUOROMETHOXYPHENYL) 9H FURO[3',4':6,7] NAPHTHO[1,2 D][1,3]DIOXOL 7 ONE;
10 (6 BROMOBENZO[1,3]DIOXOL 5 YL) 7 OXO 7,9 DIHYDROFURO[3',4':6,7]NAPHTHA[1,2 D][1,3]DIOXOLE 5 CARBONITRILE;
10 BENZO[1,3]DIOXOL 5 YL 5 BROMO 9H FURO[3',4':6,7]NAPHTHO [1,2 D][1,3]DIOXOL 7 ONE;
10 BENZO[1,3]DIOXOL 5 YL 7 OXO 7,9 DIHYDROFURO [3',4':6,7]NAPHTHO[1,2 D][1,3]DIOXOLE 5 CARBONITRILE;
10 BENZO[1,3]DIOXOL 5 YL 8 (2 HYDROXYETHYL) 1,3 DIOXA 8 AZA DICYCLOPENTA[A,G]NAPHTHALENE 7,9 DIONE;
4 BENZO[1,3]DIOXOL 5 YL 3H NAPHTHO[2,3 C]FURAN 1,5,6 TRIONE;
5 BROMO 10 (6 BROMO BENZO[1,3]DIOXOL 5 YL) 9H FURO [3',4':6,7]NAPHTHA[1,2 D][1,3]DIOXOL 7 ONE;
9 BENZO[1,3]DIOXOL 5 YL 6 HYDROXYNAPHTHO[1,2 D][1,3]DIOXOLE 7,8 DICARBAXYLIC ACID 8 METHYL ESTER;
9 BENZO[1,3]DIOXOL 5 YL 6 HYDROXYNAPHTHO[1,2 D][1,3]DIOXOLE 7,8 DICARBAXYLIC ACID DIMETHYL ESTER;
9 BENZO[1,3]DIOXOL 5 YL 6 METHOXYNAPHTHO[1,2 D][1,3]DIOXOL 7,8 DICARBAXYLIC ACID 8 METHYL ESTER;
9 BENZO[1,3]DIOXOL 5 YL 6 METHOXYNAPHTHO[1,2 D][1,3]DIOXOLE 7,8 DICARBAXYLIC ACID DIMETHYL ESTER;
9 BENZO[1,3]DIOXOL 5 YL 7,8 BIS BROMOMETHYLNAPHTHO[1,2 D][1,3]DIOXOLE;
9 BENZO[1,3]DIOXOL 5 YL 8 HYDROXYMETHYL NAPHTHO[1,2 D][1,3] DIOXOLE 7 CARBOXYLIC ACID MONOSODIUM SALT;
9 BENZO[1,3]DIOXOL 5 YL NAPHTHO[1,2 D][1,3]DIOXOLE 7,8 DICARBALDEHYDE;
9 BENZO[1,3]DIOXOL 5 YL NAPHTHO[1,2 D][1,3]DIOXOLE 7,8 DICARBAXYLIC ACID DIETHYL ESTER;
[9 BENZO[1,3]DIOXOL 5 YL 7 DIHYDROXMETHYLNAPHTHO[1,2 D][1,3]DIOXOL 8 YL] METHANOL;
ACETIC ACID 2 (10 BENZO[1,3]DIOXOL 5 YL 7,9 DIOXO 7,9 DIHYDRO 1,3 DIOXA 8 AZA DICYCLOPENTA[A,G]NAPHTHALENE 8 YL) ETHYL ESTER;
ACETIC ACID 8 ACETOXYMETHYL 9 BENZO[1,3]DIOXOL 5 YLNAPHTHO[1,2 D][1,3]DIOXOL 7 YL METHY ESTER;
ACETIC ACID 9 BENZO[1,3]DIOXOL 5 YL 8 FORMYLNAPHTHO[1,2 D][1,3]DIOXOL 7 YL METHYL ESTER;
ACETIC ACID 9 BENZO[1,3]DIOXOL 5 YL 8 HYDROXMETHYLNAPHTHO[1,2 D][1,3]DIOXOL 7 YL METHYESTER;
ANTIVIRUS AGENT;
HELIOXANTHIN DERIVATIVE;
LAMIVUDINE;
LIGNAN DERIVATIVE;
MEMBRANE ANTIGEN;
MESSENGER RNA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VIRUS DNA;
ANTIVIRAL ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CELL STRAIN HEPA2;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SYNTHESIS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
STRUCTURE ACTIVITY RELATION;
VIRUS REPLICATION;
VIRUS STRAIN;
WILD TYPE;
CELL LINE, TUMOR;
HEPATITIS B;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
LIGNANS;
PROMOTER REGIONS, GENETIC;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRAL CORE PROTEINS;
VIRUS REPLICATION;
HEPATITIS B VIRUS;
|
EID: 75149177191
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2009.12.038 Document Type: Article |
Times cited : (33)
|
References (32)
|